Schmitz et al. genetically dissected DLBCL into four subtypes: MCD (co-occurrence MYD88L265P and CD79B mutations), BN2 (BCL6 fusions and NOTCH2 mutations), N1 (NOTCH1 mutations) and EZB (EZH2 mutations and BCL2 translocations), where BN2 and EZB subtypes showed better outcome [24]. Here, BCL2 is linked to diffuse large B-cell lymphoma.